Pfizer's multivalent meningococcal vaccine was approved by the FDA.

in health •  last year 

image.png

Good stuff. Pfizer's multivalent meningococcal vaccine was approved by the FDA for individuals aged 10-25 years old. It targets serogroups A, C, W, Y, and B all in one vaccine.

We currently have two meningococcal vaccines broadly speaking targeting either B or A, C, W, and Y. Serogroup B causes most of meningococcal disease in children and young adults in the US. Serogroups C, W, and Y cause most of meningococcal disease in adults.

ACIP will meet Wednesday to determine its usage.

Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!